Protagonist Therapeutics, Inc. - Common Stock (NQ:PTGX)
151.42
-0.59
(-0.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 444,781 |
| Open | 153.15 |
| Bid (Size) | 151.42 (600) |
| Ask (Size) | 151.67 (600) |
| Prev. Close | 152.01 |
| Today's Range | 150.92 - 154.99 |
| 52wk Range | 53.49 - 152.70 |
| Shares Outstanding | 62,577,897 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Frequently Asked Questions
Is Protagonist Therapeutics, Inc. - Common Stock publicly traded?
Yes, Protagonist Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Protagonist Therapeutics, Inc. - Common Stock trade on?
Protagonist Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Protagonist Therapeutics, Inc. - Common Stock?
The ticker symbol for Protagonist Therapeutics, Inc. - Common Stock is PTGX on the Nasdaq Stock Market
What is the current price of Protagonist Therapeutics, Inc. - Common Stock?
The current price of Protagonist Therapeutics, Inc. - Common Stock is 151.42
When was Protagonist Therapeutics, Inc. - Common Stock last traded?
The last trade of Protagonist Therapeutics, Inc. - Common Stock was at 08/13/26 04:00 PM ET
What is the market capitalization of Protagonist Therapeutics, Inc. - Common Stock?
The market capitalization of Protagonist Therapeutics, Inc. - Common Stock is 9.48B
How many shares of Protagonist Therapeutics, Inc. - Common Stock are outstanding?
Protagonist Therapeutics, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
